Background illustration for clinical trials search

Paid Clinical Trials Toledo

Discover 754 paid clinical trials in Toledo, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for
Renal Cell Carcinoma (RCC),
Location: Detroit MI, Cleveland OH, Indianapolis IN,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05176483

Phase1, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Detroit MI, Cleveland OH, Fort Wayne IN,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase3, Recruiting

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Detroit MI, Cleveland OH, Columbus OH, London,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07052903

Phase3, Recruiting

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced / Metastatic Solid Tumors
Location: Detroit MI, Columbus OH, Grand Rapids MI, Pittsburgh PA,
Sponsor: Crescent Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT07335497

Phase1, Phase2, Recruiting

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

for
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Location: Detroit MI, Lansing MI, Cleveland OH, Nashville TN,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 12 - 70+

Code: NCT04647227

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

for
Infusion Reactions
Location: Detroit MI, Cleveland OH, Akron OH, Columbus OH,
Sponsor: New York Blood Center

Sex: All

Age: 0+

Code: NCT01656603

Phase2, Recruiting

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

for
Sickle Cell Disease Vaso-occlusive Crisis
Location: Detroit MI, Columbus OH, Cincinnati OH, Pittsburgh PA,
Sponsor: CSL Behring

Sex: All

Age: 12+

Code: NCT06699849

Phase2, Recruiting

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

for
Peripheral Arterial Disease
Location: Detroit MI, Cleveland OH, Kingsport TN, Dallas TX,
Sponsor: Baylor Research Institute

Sex: All

Age: 0+

Code: NCT01904851

Recruiting

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

for
Focal Onset Seizures
Location: Detroit MI, Cleveland OH, Columbus OH, Springfield IL,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT05716100

Phase3, Recruiting

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Detroit MI, Cleveland OH, Pittsburgh PA, Fairfax VA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06162221

Phase1, Phase2, Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

for
Advanced Solid Tumor
Location: Detroit MI, Cleveland OH, Grand Rapids MI,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07070232

Phase1, Phase2, Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: Detroit MI, Cleveland OH, Hamilton, Toronto, Buffalo NY,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase1, Recruiting

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

for
Advanced Melanoma
Location: Detroit MI, Columbus OH, Edgewood KY, Pittsburgh PA,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT06112314

Phase3, Recruiting

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer,
Location: Detroit MI, Canton OH, Fairfax VA, St Louis MO
Sponsor: Sairopa B.V.

Sex: All

Age: 18+

Code: NCT05856981

Phase1, Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Detroit MI, Columbus OH, Chicago IL, Toronto,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase1, Phase2, Recruiting

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Detroit MI, Columbus OH, Chicago IL, Toronto,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05118789

Phase1, Phase2, Recruiting

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Detroit MI, Columbus OH, Edgewood KY, Evanston IL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06769698

Phase2, Recruiting

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

for
Small-cell Lung Cancer
Location: Detroit MI, Cleveland OH, Mayfield Heights OH, Akron OH,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07218146

Phase3, Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for
Non-Small-Cell Lung Cancer,
Location: Detroit MI, Columbus OH, Chicago IL,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase3, Recruiting

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

for
Carcinoid Syndrome, Carcinoid, Carcinoid Tumor,
Location: Detroit MI, Cleveland OH, Milwaukee WI, Lexington KY,
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT07087054

Phase3, Recruiting